Public Health Threat For EU Patients If IVDR Implementation Issues Remain Unaddressed
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
You may also be interested in...
If the tools are not in place by the end of 2020 to allow diagnostics companies to comply with the EU IVDR, the 2022 compliance deadline should be delayed, say EU notified bodies.
Royal Philips closed out the first year of COVID-19 with 7% revenue growth in the fourth quarter. CEO Frans van Houten says low single digit growth is the target for fiscal 2021.
There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.